The circadian system, or circadian clock, provides an adaptive advantage for organisms ranging from archaea to humans to the 24-hour periodicity in the Earth's rotation 1 . The growing list of physiological processes controlled by the circadian clock includes metabolism, hormone secretion and cardiac function, all of which exhibit daily oscillations. The circadian system also maintains the internal coordination of multiple oscillators within and between various organ systems in order to increase the fitness of an organism and to provide the organism with the most efficient response to the environment 2-5 . In humans, dysfunction of the circadian clock induced by shift work, for example, significantly increases the risk of developing metabolic syndromes, cardiovascular diseases and cancer, thereby indicating that these circadian-clock-controlled processes have key roles in human physiology and pathology 6 . Although the molecular mechanisms underlying these processes are unknown, it has been suggested that shift work leads to the resynchronization of circadian oscillators, thereby uncoupling different organ systems from each other and from the central pacemaker 5 . A connection between the circadian clock and ageing has been recently proposed 7 . Whereas the effect of ageing on the performance of the circadian system has been known for many years 8 , recent data show that a dysfunctional circadian clock can also contribute to ageing and to pathologies associated with old age 9 . Here, we discuss a potential role of the circadian clock in the age-associated decline of brain function, with a specific emphasis on age-associated brain disorders and neurodegenerative diseases. Although it is sometimes difficult to dissociate the effect of sleep abnormalities on cognition and mood from circadian clock dysfunction, multiple lines of evidence suggest that the activity of the circadian clock in the regulation of cognition and mood is far beyond the circadian control of sleep and the restactivity cycle. Here, we focus on the relationship between the circadian clock and brain ageing with an emphasis on sleep-independent mechanisms. The role of sleep in age-associated cognitive decline has been recently reviewed 10 and is beyond the scope of this article.
The circadian system, or circadian clock, provides an adaptive advantage for organisms ranging from archaea to humans to the 24-hour periodicity in the Earth's rotation 1 . The growing list of physiological processes controlled by the circadian clock includes metabolism, hormone secretion and cardiac function, all of which exhibit daily oscillations. The circadian system also maintains the internal coordination of multiple oscillators within and between various organ systems in order to increase the fitness of an organism and to provide the organism with the most efficient response to the environment [2] [3] [4] [5] . In humans, dysfunction of the circadian clock induced by shift work, for example, significantly increases the risk of developing metabolic syndromes, cardiovascular diseases and cancer, thereby indicating that these circadian-clock-controlled processes have key roles in human physiology and pathology 6 . Although the molecular mechanisms underlying these processes are unknown, it has been suggested that shift work leads to the resynchronization of circadian oscillators, thereby uncoupling different organ systems from each other and from the central pacemaker 5 .
A connection between the circadian clock and ageing has been recently proposed 7 . Whereas the effect of ageing on the performance of the circadian system has been known for many years 8 , recent data show that a dysfunctional circadian clock can also contribute to ageing and to pathologies associated with old age 9 . Here, we discuss a potential role of the circadian clock in the age-associated decline of brain function, with a specific emphasis on age-associated brain disorders and neurodegenerative diseases. Although it is sometimes difficult to dissociate the effect of sleep abnormalities on cognition and mood from circadian clock dysfunction, multiple lines of evidence suggest that the activity of the circadian clock in the regulation of cognition and mood is far beyond the circadian control of sleep and the restactivity cycle. Here, we focus on the relationship between the circadian clock and brain ageing with an emphasis on sleep-independent mechanisms. The role of sleep in age-associated cognitive decline has been recently reviewed 10 and is beyond the scope of this article.
Organization of the circadian clock
Virtually all tissues in an organism exhibit circadian oscillations in gene expression, thereby underscoring the importance of the circadian clock throughout the body. Multiple reviews on the anatomical and physiological organization of the circadian clock have recently been published 6, 7, 11 ; therefore, here we provide only a short overview of the circadian clock system and the molecular components that form the circadian oscillator in the mammalian cell (FIG. 1a) . The central, or master, circadian clock is located in the suprachiasmatic nucleus (SCN) of the anterior hypothalamus 12 . SCN neurons generate rhythmic electrical activity and produce synchronizing signals that control the phases of the oscillations of so-called peripheral clocks operating in other tissues, such as the liver, heart and muscles. The rhythmic activity of the SCN is synchronized with external light cues through signals from the retina. Peripheral tissues produce rhythmic physiological outputs that are orchestrated by the SCN and are synchronized with the environment, thereby allowing an organism to function or respond to its environment in an optimal manner at specific times of the day 13 . In humans, pathologies associated with shift work underscore the importance of such synchronization 5 . The mechanisms underlying circadian rhythms involve circadian oscillations in gene expression, in protein modifications and hormone secretion. These oscillations are controlled by the products of core circadian clock genes 14 . Experiments in model organisms in which single or multiple clock genes have been deleted or mutated have revealed genes that are critically important for circadian rhythms in locomotion, behaviour, physiology and gene expression. The current model connects these circadian clock genes and their products in transcriptional-translational feedback loops 15, 16 (FIG. 1b) .
Clock gene products that are positive regulators of transcription include BMAL1 (brain and muscle ARNTlike 1), its interacting partners CLOCK (circadian locomotor output cycles kaput) or NPAS2 (neuronal PAS domain-containing protein 2), and retinoid-related orphan receptors (RORs). Clock gene products that are negative regulators of transcription include cryptochrome (CRY) flavoproteins, period (PER) proteins and Rev-Erbα. The functions of CLOCK and NPAS2 proteins are partially redundant. The BMAL1-CLOCK complex or BMAL1-NPAS2 complex specifically interact with and modify chromatin, which results in an upregulation of the expression of a set of genes, including Cry and Per genes. The expressed CRY and PER proteins form a complex that inhibits the activity of the BMAL1-containing complexes and thereby downregulate their own expression, thus forming a negative feedback loop. Rhythmic expression of Per1 and Per2 genes at the mRNA level can be detected in almost all tissues and serves as an indicator of circadian clock activity. Additional loops are formed with the help of Rev-Erbα and RORs, which fine-tune the oscillations generated by the main loop 17 . Post-translational modifications and degradation of circadian proteins provide additional levels of regulation 18 . It is also worth mentioning that although Bmal1 is the only circadian clock gene with a non-redundant clock function 19 , it can be functionally (neuronal PAS domain-containing protein 2) -regulate the transcription of genes with circadian E-box elements in the promoter. These transcription factors also represent positive elements of the transcriptional-translational feedback loop. The BMAL1-CLOCK complex activates the expression of period (Per) and cryptochrome (Cry) genes. PER and CRY represent negative elements of the loop; they form complexes and inhibit the activity of BMAL1-CLOCK and hence their own expression. Rev-Erbα and retinoic orphan receptors (RORs) represent an additional loop; Rev-Erbα negatively regulates the expression of BMAL1, whereas RORs positively regulate the expression of BMAL1. Finally, the BMAL1-CLOCK complex regulates the expression of circadian-clock-controlled genes (CCGs), which provide a circadian output in physiology. The clock, sleep, mood and cognitive function The expression of circadian clock genes rhythmically oscillates in different brain structures outside the SCN, which suggests that multiple circadian clocks exist in the brain. It has been proposed that the synchronized activity of these clocks is critically important for a number of mental processes and that a loss of phase coherence between these clocks (under the influence of shift work, for example) can negatively affect cognitive function 5, 21, 22 . The regulation of sleep by the circadian clock is well established; however, recent work has shown that the circadian clock is also involved in the regulation of mood, memory and adaptation to novelty 23 
.
Sleep is controlled by an interaction between the homeostatic drive for sleep and circadian-clock-generated signals. Local circadian clocks are present in the brainstem, thalamus and cortex -these brain structures are associated with sleep control. Circadian control of neural activities in these centres is important for daily rhythms of wakefulness and sleep. Deficiency in the circadian clock induced by targeted disruption of clock genes impairs sleep in mice 5 . The importance of the circadian clock in sleep control in humans has also been demonstrated: a mutation in the PER2 gene has been found to be responsible for familial advanced sleep phase syndrome, whereas delayed sleep phase syndrome has been linked with polymorphisms in clock genes 5 . Several lines of evidence link the circadian clock and mood regulation 24 . Linkage analysis studies in humans list circadian clock genes as candidates for the susceptibility of developing major depression, bipolar disorder and seasonal affective disorder 25 . Another connection has been shown in rodents: mice with a particular mutation in the Clock gene demonstrate mania-like behaviour that has been attributed to increased dopaminergic activity in the ventral tegmental area 26 . Interestingly, drugs used for treating mood-related disorders directly regulate the activity and expression of circadian clock genes 27 . These results suggest that an impaired circadian clock significantly affects mood in experimental animals and is most likely a contributory factor to mood-related disorders in humans.
The role of the circadian clock in cognition and especially in memory formation and consolidation is currently an active area of research 28 . The circadian clock probably regulates memory though several mechanisms. One potential mechanism involves the circadian control of sleep: indeed, consolidation of procedural and declarative memory is sleep-dependent, and the quality and duration of sleep is critical for cognitive functions. However, a growing body of evidence indicates that the involvement of the circadian clock in memory formation and/or consolidation is independent from its role in the regulation of sleep. Recent studies in animals in which different components of the circadian clock have been disrupted demonstrated impaired contextual, spatial and time-related memory, as well as impaired adaptation to a novel environment [29] [30] [31] [32] [33] . Moreover, targeted disruption of circadian genes leads to defects in particular types of memory task, but not others. For example, mice that are deficient in both CRY1 and CRY2 (Cry1 -/-Cry2 -/-) exhibit a deficit in time and place learning, but not in other types of associated learning 31 .
Per2
-/-mice demonstrate impairments in trace fear memory formation, but not in cued fear memory formation 34 .
Npas2
-/-mice have impaired cued and contextual fear memory formation 32 .
Finally, Bmal1
-/-and Cry1 -/-Cry2 -/-mice demonstrate opposing novelty-induced behaviours and habituation 29 .
In humans, cognitive abilities are known to fluctuate throughout the day. To separate the sleep and the circadian-clock-dependent components of this fluctuation, the sleep-wake cycle and the circadian clock cycle were completely desynchronized through a forced non-24-hour day, in which subjects followed 20-hour or 28-hour rest-activity schedules. Under these extreme conditions the internal circadian clock cannot be adjusted to external cues and continues to run at its intrinsic period of about 24 hours. When performance in an addition-subtraction test and a psychomotor vigilance task were evaluated, the authors found that the subjects' abilities had a clear circadian profile, which suggests that the circadian clock has a sleep-independent effect on cognitive function in humans 35 . What molecular mechanisms could be engaged by the circadian system to control brain function? Long-term potentiation (LTP) requires activation of the transcription factor cAMP-responsive element-binding protein (CREB) through the mitogen-activated protein kinase (MAPK) and cyclic AMP-dependent pathways. In the mouse hippocampus, the level of cAMP, phosphorylation of MAPK (which is a sign of activation of MAPK), and CREB-dependent transcription exhibit circadian oscillations that peak during the sleep phase. Physiological and pharmacological interferences with circadian rhythms in MAPK phosphorylation significantly impair hippocampus-dependent memory formation 36 . Thus, the circadian control of the cAMP-MAPK-CREB signal transduction pathway provides a potential mechanistic explanation for the circadian control of memory formation 37 . Another potential molecular mechanism is the synchronization of local clocks throughout the brain. Temporal compartmentalization of metabolic and replication cycles in yeast was demonstrated to protect the cells' genome 38, 39 . A similar 'temporal partitioning' was suggested for the circadian-clock-dependent control of metabolic processes in peripheral tissues, specifically in the liver [40] [41] [42] [43] [44] . According to this model, the phases of daily cycles of hepatic gene expression are locked by SCN signalling and, thus, local enzymatic activity is synchronized with the metabolic demands of activity and sleep 13, [40] [41] [42] [43] [44] . Likewise, if circadian clock genes are expressed in the hippocampus, cortex, amygdala and other structures with different phases, the internal synchronization of these local brain clocks imposed by the SCN pacemaker 45 may affect cognition. Thus, during waking hours, the gene expression pattern must support
Synaptic rewiring
Also known as synaptic plasticity, this is a process of formation and elimination of synapses in the nervous system. brain functions such as acquisition, responsiveness and processing of stimuli 5 . By contrast, during sleep, when the process of short-term memory consolidation occurs, the gene expression pattern must support synaptic rewiring 5 . However, at present, there is no direct experimental support of this model.
Neoneurogenesis is an essential component of cognition 46 and may also be a mechanism through which the circadian clock regulates cognitive function. Circadianclock-dependent regulation of neoneurogenesis has been proposed on the basis of a few observations showing that neurogenesis among the olfactory projection neurons in lobsters fluctuates with the light-dark cycle 47 . A similar fluctuation in cell proliferation in the dentate gyrus of the adult rat has also been reported 48 . However, it is unclear whether the observed rhythms in cell proliferation are due to true circadian control or whether they are coupled to daily patterns of activity or sleep.
Circadian clock and ageing
Ageing is a complex biological process that affects the activity of many physiological systems, including the circadian clock 7, 8 . Functional weakening of the circadian system with age has been known for many years. The effect of ageing on circadian clock activity has been reported in different model organisms, including invertebrates [49] [50] [51] [52] , rodents 53 and primates 54 , thus suggesting that the effect of ageing on the circadian system is highly conserved in evolution.
Phase advance and reduced amplitudes of circadian rhythms of temperature and hormone secretion (specifically melatonin and cortisol) have been detected in aged humans 8, 55 . However, there are discrepancies between studies on the effect of ageing on melatonin secretion and body temperature rhythms 56 . A reduction of circadian amplitude was reported in several studies, but predominantly in old males 56 . By contrast, no reduction in amplitude was observed in old females 56, 57 . The sensitivity of the circadian system to light is dramatically reduced with age as measured by the induction of c-Fos expression in the SCN of hamsters 58 , mice 59 and primates 60 . This reduced response to light may contribute to the impaired entrainment of the circadian clock by light cues in aged rats 61 . Ageing does not have an effect on the size or the number of neurons in the SCN 62 ; however, a decrease in the number of vasopressin-expressing neurons has been found in the SCN of aged rats 63 . Ageing contributes to major changes in electrophysiological and neurochemical outputs of the SCN 64 . The amplitude of the electrophysiological 65 and hormone-secreting activity 66 and gene expression levels 67, 68 in SCN cells all decline in the ageing brain. These age-associated changes in the SCN have been proposed to be responsible for the impairment of circadian clock synchronization throughout the body 8 . In mice, disruption of the circadian system by targeted deletions of clock genes significantly affects the rate of ageing. Deficiency in the transcription factor Bmal1 results in the development of a premature ageing phenotype, which is characterized by multiple age-related pathologies and an almost threefold reduction in lifespan 69 . Interestingly, fruitflies that have a mutation in the cycle gene (a Drosophila spp. homologue of Bmal1) have reduced longevity 70 , although the effect is genderspecific as lifespan is reduced only in males. These findings suggest that the role of Bmal1 in ageing is conserved in evolution.
In mice, deficiency of CLOCK (Clock
) results in an increased rate of inflammation, development of cataracts and a 15% reduction in longevity 71 . The lifespan of mice with mutations in both Clock and Per2 genes have not been reported; however, after exposure to non-lethal doses of ionizing irradiation these mutant mice have a reduced lifespan and some ageing-associated phenotypes 72, 73 . They do not develop the accelerated ageing phenotype that is characteristic for Bmal1 -/-mice and so, although disruption of the circadian clock affects the rate of ageing regardless of the particular mechanism of disruption, the activity of some clock proteins, such as BMAL1, is more important in the control of ageing than the activity of other proteins, such as CLOCK or PER. This suggests that circadian clock proteins have noncircadian roles in ageing (see also REFS 53, 74) .
The clock and age-associated cognitive impairment Both healthy and pathological brain ageing are associated with multiple impairments in cognitive function. Sleep duration, quality and pattern, together with phases of sleep and wakefulness, are considerably different in elders 75, 10 . An ageing-related decline in spatial, declarative and other forms of memory is well documented 10, 76, 77 . Furthermore, changes in mood regulation, for example, increased frequency of episodes of depression, mania and anxiety, are also observed with age [78] [79] [80] . How does the circadian clock contribute to these processes?
A potential role of the circadian clock in brain ageing is illustrated in FIG. 2. A decline in clock functions contributes to sleep impairments 21, 22 , but, as mentioned above, the effect of an ageing circadian system on cognitive functions may be both sleep-dependent and sleepindependent. It is difficult to distinguish between these effects. For example, sleep is important for memory consolidation, thus, the disruption of normal sleep patterns as a result of circadian clock ageing can be one of the contributors to memory impairment 5, 10 . In agreement with this, flattened amplitude of circadian activity in aged rats is associated with a deficit in long-term (sleep-dependent) spatial memory, whereas working memory is unaffected 81 . Similarly, sleep-independent mechanisms of clock-controlled memory and mood (discussed above) would also be impaired upon ageing of the circadian clock. Ageing of the circadian system is not equivalent to the disruption of the circadian clock induced by mutations. However, the cognitive changes observed in animal models in which circadian clock genes are mutated could reflect to a certain extent the cognitive changes observed in the ageing brain. Further exploration of the role of specific circadian proteins in the control of cognition, sleep and ageing using genetically engineered animal models may provide some clues about how ageing of the circadian clock contributes Nature Reviews | Neuroscience Ageing is associated with a decline in the activity of the circadian system. This decline, in turn, can contribute to ageing and to age-associated changes in sleep quality, memory and mood. Neurodegeneration is also associated with ageing and affects sleep quality and circadian clock functions; this disruption of sleep and circadian rhythms will affect cognitive functions. It is possible that the circadian clock is involved in the control of neurodegeneration. Potential circadian clock-independent effects of ageing and neurodegeneration on cognitive functions are omitted for simplicity.
to age-related cognitive dysfunctions and might help to separate the effects of circadian rhythms and sleep on cognition.
Neurodegenerative diseases and the clock Ageing of the circadian system contributes to the decline in mental performance of aged brains, but the circadian clock may also be involved in specific age-associated neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Huntington's disease 22 . Indeed, multiple clinical studies have demonstrated that while each of these three pathologies have their unique pathological signatures, the disruption of sleep and circadian rhythms is one of the common and earliest signs of these diseases. That is, abnormalities in the circadian clock and in sleep quality worsen as the disease progresses 22, 82 (see details on neurodegeneration-associated circadian disruption in BOX 1) .
Degeneration of brain nuclei that contain sleep circuits and circadian clock-regulating circuits in the SCN 83, 84 , hypothalamus [85] [86] [87] , basal forebrain 85,88 and brainstem 87, 89, 90 is one of the possible causes of sleep defects in patients with neurodegenerative diseases. These brain structures release different neurotransmitters in a rhythmic manner. During wakefulness, excitatory neurotransmitters such as adrenaline, serotonin and histamine are released, whereas the release of inhibitory neurotransmitters such as GABA and galanin is suppressed. Disruption of this neurotransmitter release-suppression pattern with age or as a result of neurodegeneration may contribute to defects in sleep and circadian clock activity 22 . The negative effect of neurodegeneration on the circadian clock has been confirmed in animal models of Alzheimer's disease 91 , Parkinson's disease 92 and Huntington's disease 93 . The correlation between neurodegeneration and circadian clock dysfunction raises important questions. First, is the circadian system involved in the pathophysiology of neurodegenerative diseases? If it is, how does the circadian clock affect the development of neurodegenerative diseases? It seems that on the one hand, the intact circadian system may have neuroprotective functions, whereas on the other hand, disruption of the circadian clock seems to promote neurodegeneration. Hypothetical connections between the circadian clock and neurodegeneration are illustrated in FIG. 3 and are discussed in more detail below.
One of the main features of the three abovementioned neurodegenerative diseases is increased oxidative stress 94 . In Alzheimer's disease, oxidative damage leads to an increased accumulation of DNA oxidation products in the nuclei of neurons and in elevated levels of oxidized proteins and lipids, which can be found in plaques and neurobrillary tangles. In Parkinson's disease, the products of protein oxidation and lipid peroxidation can be detected in Lewy bodies. Dysfunctions in mitochondria have been shown in patients with Huntington's disease, and increased oxidative stress was reported in a mouse model of this disease. Increased oxidative damage results in the death of neurons, astrocytes and oligodendrocytes, as well as degeneration of normal brain structures. Possible mechanisms underlying the increase in oxidative stress include dysfunction of damaged mitochondria, overactivation of microglia, formation of protein and lipid plaques, and reduced antioxidant defence 94 . Weakened antioxidant defence in the ageing brain may contribute to increased oxidative stress; however, the mechanisms involved are unknown 95 . The role of the circadian system in the regulation of reactive oxygen species (ROS) homeostasis is well established. ROS levels oscillate in different mouse tissues 69 and these rhythmic patterns are disrupted in mice with impaired circadian clocks. An imbalance of ROS levels was proposed as a potential mechanism of premature ageing in BMAL1-deficient mice; in agreement with this, treatment with the antioxidant N-acetyl-l-cysteine increased the longevity of these animals 96 . Daily oscillations in the level of the products of lipid and protein oxidation have been observed 97 . The circadian clock can orchestrate antioxidant defence by controlling the daily oscillation in the expression of antioxidant enzymes and low-molecularmass antioxidants.
Potential mechanistic links between the circadian clock and ROS homeostasis have been studied in model organisms. In Neurospora crassa, the circadian clock may regulate ROS levels through the small membrane-anchored G-protein ras-1 (REF. 98 ) and through regulation of catalase expression and activity 99 . In Drosophila melanogaster, the sensitivity to oxidative stress, protein carbonylation and hydrogen peroxide production changes throughout the day, and these rhythms are disrupted in mutants bearing a null mutation in the per gene. Reduced activity of catalase in these fruitflies bearing circadian mutations may be responsible for their increased sensitivity to oxidative stress 100 . It is possible that a similar mechanism regulates ROS homeostasis in mammals. In agreement with the importance of the circadian clock in the regulation of redox states, circadian rhythms of peroxiredoxin oxidation have been observed in nucleated and enucleated (red blood) cells 101 . Similar transcription-independent circadian rhythms were observed in picoplankton alga Ostreococcus tauri 102 ; however, the underlying mechanisms for these phenomena are unknown in both cases.
Nevertheless, although not demonstrated directly, it is possible that the circadian clock directly regulates ROS production. Multiple reports link the circadian clock with daily oscillations in metabolism and body temperature, and, in turn, metabolic rhythms are intimately linked with the activity of the mitochondria and ROS generation as a by-product of oxidative catabolism. Many metabolic enzymes and metabolism-regulating growth factors and hormones are under the direct control of the circadian clock 13 . Indeed, disruption of the circadian clock leads to numerous defects in metabolism and to the development of metabolic syndromes, which are known to be associated with increased oxidative damage. If, similar to the regulation of metabolism of the liver and other peripheral organs, the circadian clock regulates metabolism in the brain, one can expect that disruption of this regulation will lead to oxidative damage. Death of brain cells, especially neurons and astrocytes, is a hallmark of neurodegeneration. Because differentiated neurons are unable to divide, mechanisms to repair damage are critical to the physiology of the neuron. Indeed, accumulation of damaged DNA may lead to the activation of apoptotic programmes; damaged proteins and lipids may form aggregates and intracellular and extracellular inclusions; and damaged organelles, such as mitochondria, can directly induce cell death. Several mechanisms responsible for the elimination of damaged macromolecules may also be under the control of the circadian clock.
ROS are constantly produced in the brain as metabolic by-products and probably as signal molecules. It is known that oxidative stress is one of the main triggers of brain cell death, and that repair of oxidized DNA is crucial for the survival of brain cells. Nucleotide excision repair systems remove two major products of DNA oxidation: 8-oxoguanine and thymine glycol. Nucleotide excision repair activity rhythmically oscillates during the day with peak activity occurring in the early evening 103 .
In agreement with this, one of the DNA-damage recognition proteins, the core excision repair factor xeroderma pigmentosum A, exhibits a circadian, time-dependent oscillation. Thus, it was proposed that circadian control of nucleotide excision repair plays an important part in neuroprotection 104 . This role may be especially important in neurodegenerative diseases, which are associated with increased oxidative stress: disruption of the normal clock functions may result in reduced removal of DNA lesions and increased neuron death.
The three neurodegenerative diseases discussed above are associated with the deposition of aggregates in the brain: amyloid-β plaques and neurofibrillary tangles in patients with Alzheimer's disease, Lewy bodies in patients with Parkinson's disease and huntingtin-containing neuronal inclusion bodies in patients with Huntington's disease. This suggests that there is some failure in the systems responsible for the degradation of damaged proteins and other cytoplasmic components. The ubiquitin-proteasome-dependent system and autophagy are the two major systems responsible for the degradation of cellular proteins, including misfolded and damaged proteins 105, 106 . Autophagy is also responsible for the degradation of lipids and non-functional or damaged organelles such as mitochondria and peroxisomes. Although there is a major difference among the pathologies and causes of Alzheimer's disease, Parkinson's disease and Huntington's disease, defects in autophagy have been reported in all of these diseases 106 . The mechanisms of autophagy deregulation in neurodegeneration are mostly unknown, but some insights have been provided by recent studies 106 . In patients with Alzheimer's disease the clearance of autophagic amyloid-β-containing vacuoles is defective, and an increased autophagic degradation of mitochondria is another pathological change observed 106 . In
Box 1 | Circadian disruption in age-associated neurodegenerative diseases
Alzheimer's disease Alzheimer's disease (AD) is the most common neurodegenerative disease in aged humans. It is characterized by progressive dementia, memory impairment, mood changes and disrupted circadian rhythms. The anatomical feature of AD is a degeneration of multiple regions of the brain 137 . Degeneration in the ventrolateral preoptic nucleus, suprachiasmatic nucleus and basal forebrain is, almost certainly, responsible for problems with sleep and circadian rhythms 138 . The nocturnal production of melatonin is also significantly reduced. The histological hallmarks of AD are extracellular protein deposits in which amyloid-β peptide is a main component (leading to senile amyloid plaques) together with intraneuronal aggregates of hyperphosphorylated microtubule-associated protein tau (leading to neurofibrillary tangles) 137 . Senile plaques and tangles have essential roles in the generation of reactive oxygen species. Oxidative stress is, most likely, responsible for the death of neurons and astrocytes in the brains of patients with AD 94 .
Parkinson's disease
Parkinson's disease (PD) is a neurodegenerative disease that significantly affects a patient's motor functions. Typical pathological features are bradykinesia, tremor and rigidity 139 . PD is associated with a progressive loss of the substantia nigra dopaminergic neurons. Intracytoplasmic inclusions termed Lewy bodies formed by α-synucleincontaining aggregates and dystrophic neuritis are the most common anatomical abnormalities observed in the brains of patients with PD 140 . PD is associated with reduced mitochondrial function and increased oxidative damage to lipids, proteins and DNA; protein and lipid aggregates found in Lewy bodies are generally oxidized. Evidence of circadian disruption in patients with PD include significant sleep disturbance and problems with the ability to fall and/or stay asleep 141 . There are also indications for disrupted rhythms of melatonin release.
Huntington's disease
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. Pathological features are cognitive impairment, motor skill impairment and premature death 142 . The disease is caused by the expansion of a trinucleotide repeat in the huntingtin gene (HTT), which leads to the formation of a polyglutamine tract at the amino terminus of the protein. The mutated protein cannot be efficiently degraded and forms aggregates that lead to the accumulation of neuronal inclusion bodies. It was proposed that the inclusion bodies affect mitochondrial function and increase oxidative stress, which cause death of striatal neurons and astrocytes 142 . Atrophy of the lateral hypothalamus was suggested to contribute to the disruption in circadian timing in patients with HD 143 . 
Mitophagy
Mitophagy is a process of removing mitochondria through macroautophagic pathways.
Light therapy
An experimental therapy that has been used to treat disorders associated with disrupted circadian rhythms. Patients are exposed to light (daylight or artificial light) of defined intensity at specific times of the day.
patients with Parkinson's disease, autophagosomes accumulate, lysosome-dependent degradation of α-synuclein is impaired and targeting of damaged mitochondria for degradation through mitophagy is defective 106 . Defective autophagy has also been implicated in the degradation of huntingtin aggregates, and general protein turnover is reduced in patients with Huntington's disease. The current model suggests that defects in cargo recognition result in autophagic vacuoles that contain minimal cargo 106 . However, the relationship between autophagy and neurodegeneration is complex; autophagy must be tightly regulated as both suppression and overactivation of autophagy can be dangerous 106 . The circadian clock is one of the potential systems for finely regulating autophagic activity 107 . Daily rhythms of autophagy in rat hepatocytes and cardiomyocytes 108 (with activity peaking near to resting phase and at a minimum at the time of feeding) have been reported. Similar oscillations have also been reported in the kidney 109 and retina 110 . The physiological significance of these rhythms is unclear, as is whether the circadian clock is involved in the control of autophagy. The expression of several genes associated with autophagy rhythmically oscillate in the liver in a circadian manner, thereby suggesting a molecular connection between the circadian oscillator and autophagy 107 . C/EBPβ was identified as a key link between autophagy and the circadian clock; this transcription cofactor can activate autophagy in vitro, it is rhythmically expressed in the liver and the disruption of its circadian expression in mice lacking a functional liver clock correlates with disrupted rhythms in autophagy in the liver 111 . If, as is the case in the liver and the heart, autophagy has rhythmic variations in the brain, the disruption of circadian oscillations could lead to the accumulation of aggregates and damaged mitochondria, thus contributing to the development of neurodegenerative diseases and other age-associated brain dysfunctions.
Another potential link connecting the circadian clock and neurodegeneration is the activity of melatonin 112 . Melatonin is a peptide hormone that is produced by the pineal gland in a circadian manner. It has a myriad of activities, such as intracellular signal transduction and regulation of cell death and proliferation. Melatonin is also produced by other tissues in the body, but pineal gland production is the most relevant on brain function. The most studied melatonin function is its antioxidant activity. It was demonstrated that melatonin can be more efficient than many classical antioxidant scavengers such as vitamins E and C
112
. Melatonin is a naturally synthesized compound, and its high local concentration in the brain and cerebrospinal fluid makes it a highly attractive candidate to provide a molecular connection between the circadian clock and neuroprotection. Indeed, disrupted production of melatonin can significantly compromise the normal brain antioxidant defence. Additionally, melatonin production decreases with age, and could be a predisposing factor for neurodegeneration 113, 114 and mood disorders 115 . The circadian production of melatonin is affected in Alzheimer's disease, Parkinson's disease and Huntington's disease 112 . Reduced amplitude, earlier timing of peak levels and diminished amounts of total secretion of melatonin have been reported in patients with Alzheimer's disease 55, 116 . In patients with Huntington's disease, the timing of the evening peak in melatonin level is delayed considerably, but total secretion is not different from the control group 117 . Melatonin therapy (oral administration of the hormone) has recently been used for the treat ment of Alzheimer's disease and Parkinson's disease, but its efficacy is unclear (see next section).
Overactive glia and impaired immune functions have also been proposed to contribute to the development of Alzheimer's disease, Parkinson's disease and Huntington's disease. It was recently demonstrated that disruption of circadian clock function affects the release of inflammatory cytokines in response to endotoxin 118 or lipopolysaccharide challenge 119 . One of the potential mechanisms underlying this effect is the circadianclock-dependent production of cortisol, which is a powerful regulator of the activity of the immune system. The daily oscillation of cortisol levels is considerably affected by ageing; thus, a defect in cortisol secretion may contribute to an imbalance in the regulation of the immune system and to the pathology of age-associated diseases.
Modulation of the clock and brain ageing Light therapy and melatonin treatments have been used for a long time as mechanisms to reset the circadian clock in humans. Several studies have reported promising effects of light therapy and melatonin treatment on the progression of neuropsychiatric diseases in aged people and in people suffering from specific disorders 120 . In patients with Alzheimer's disease, treatment with melatonin had mixed results: no significant improvements in the quality of sleep between the melatonin-treated groups and the control groups were reported in several double-blind, randomized, placebo-controlled studies [121] [122] [123] . However, as the effects of melatonin are dependent on the phase of the circadian cycle, combinations of melatonin and bright-light therapy significantly improved the quality of sleep and daytime activity of patients according to other studies 124, 125 . Mild cognitive impairment (MCI) is an aetiologically heterogeneous syndrome, with about 12% of MCI cases being associated with Alzheimer's disease. Melatonin alone or in combination with light therapy had significant beneficial effects in patients with MCI 112 . In mouse models of Alzheimer's disease, treatment with melatonin inhibited oxidative and amyloid-β pathology, protected against cognitive deficits and neurodegeneration and increased survival 126, 127 . Interestingly, in vitro, melatonin interacts with amyloid-β protein and inhibits the formation of amyloid fibrils 128 .
Although melatonin treatment demonstrated a significant neuroprotective role in an animal model of Parkinson's disease 129 , there is controversy about its efficacy in the clinic. In one study 130 , use of melatonin in combination with bright-light exposure improved sleep quality in patients with Parkinson's disease, thereby suggesting that the circadian clock can be used not only as early marker of the disease, but as a means of potential therapeutic intervention. However, according to other studies, melatonin does not demonstrate any therapeutic effects [131] [132] [133] , thus, more research on the potential of melatonin as a treatment for Parkinson's disease is necessary.
Encouraging data from recent studies in experimental organisms suggest that it is possible to delay the development of neurodegenerative disease by treating sleep abnormalities and improving circadian clock functions. In a mouse model of Huntington's disease, restoration of the daily rest-activity cycle with the benzodiazepine alprazolam restored dysfunctional circadian clock gene expression, improved cognitive performance and significantly extended the lifespan of these mice 134, 135 . Scheduled feeding can also restore daily behavioural rhythms in this model, but the effect of this intervention on the development of pathology has not been reported 136 .
It is also noteworthy that many pharmacological drugs used for the treatment of neuropsychiatric disorders affect the function of the circadian clock, which leads to the possibility that they may, at least partially, act by restoring circadian clock function. Will the resetting of the circadian clock help to delay the decline in cognitive functions during normal ageing? To the best of our knowledge, no studies have been published yet on this subject.
Conclusions and future directions
During the past several decades human lifespan has dramatically increased, thereby creating a new level of challenges for biomedical sciences. Chiefly, how to improve the quality of life of the aged population and promote healthy ageing. Diseases of the ageing brain, specifically neurodegenerative diseases, attract significant attention because the incidence of these pathologies is on the rise. To develop rational strategies for the prevention and treatment of these diseases, it is necessary to identify the molecular pathways associated with these pathologies. The circadian clock is one of the body's physiological systems that has been recently linked to the control of ageing. It is becoming clear that the physiological function of the circadian clock is relevant for multiple brain functions, including sleep, mood and memory. Therefore, ageing of the clock affects these functions and contributes to age-associated cognitive decline. Circadian-clockdependent control of several pathways that are known to be involved in the pathology of neurodegeneration -such as metabolism, ROS homeostasis and oxidative stress response, DNA damage repair and, potentially, autophagy -suggests that defects in circadian clock functions may have causative roles in Alzheimer's disease, Parkinson's disease and Huntington's disease.
Many questions, however, still remain to be answered. The hypothesis that the circadian clock is involved in the regulation of oxidative stress in the brain needs to be tested. Is the circadian clock involved in daily metabolic processes in the brain? How is this related to ROS generation? Is the circadian clock involved in brain antioxidant defence? What are the molecular mechanisms responsible? Is the beneficial effect of melatonin on the pathology of neurodegenerative diseases associated with restoration of circadian clock function, with the antioxidant properties of melatonin or with some other melatonin function? The use of mouse strains that do not produce significant amounts of melatonin may shed some light on this issue. The therapeutic effect of melatonin was demonstrated in a mouse model of Alzheimer's disease, therefore, it is possible to test whether circadian clock functions are important for melatonin function by crossing Alzheimer's disease transgenic mice with circadian clock mutant mice and investigating the effect of melatonin in the generated hybrids. Is the circadian clock involved in the control of autophagy in the brain? And, if the clock is involved, does ageing-associated impairment of the circadian clock contribute to the deposition of extracellular and intracellular aggregates in neurodegenerative diseases? Finally, several potential pharmacological modulators of the circadian clock in vitro have been reported recently. If the biological activity of these modulators is confirmed in vivo, they need to be tested in animal models of neurodegeneration. It will be important to see whether they improve the function of the circadian clock under pathological conditions and, more importantly, to see whether the development of the disease is affected.
The evidence available so far warrants further research into the role of the circadian clock in the regulation of normal and pathological brain physiology. Targeting the circadian clock could be a novel direction for the diagnosis and treatment of disorders of the ageing brain, including neurodegenerative conditions.
